Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.881 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8634 |
High Similarity |
NPD2801 |
Approved |
0.8623 |
High Similarity |
NPD3818 |
Discontinued |
0.8571 |
High Similarity |
NPD7054 |
Approved |
0.8535 |
High Similarity |
NPD1511 |
Approved |
0.8521 |
High Similarity |
NPD7472 |
Approved |
0.8471 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8452 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8428 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8421 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8412 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8354 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8293 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8266 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8253 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8166 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8098 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8084 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8072 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8065 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8024 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7965 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7965 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7914 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7914 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7901 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7824 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7797 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.779 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7764 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD6799 |
Approved |
0.774 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7701 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD37 |
Approved |
0.7688 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.767 |
Intermediate Similarity |
NPD7228 |
Approved |
0.767 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7661 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7661 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7661 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7619 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7616 |
Intermediate Similarity |
NPD3749 |
Approved |
0.761 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7605 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD5403 |
Approved |
0.759 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7586 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7574 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7572 |
Intermediate Similarity |
NPD919 |
Approved |
0.7547 |
Intermediate Similarity |
NPD943 |
Approved |
0.7547 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7531 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8312 |
Approved |
0.75 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.75 |
Intermediate Similarity |
NPD2800 |
Approved |
0.75 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD920 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7458 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7443 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7421 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7381 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7345 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7345 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7321 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7259 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7253 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7216 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7213 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7202 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7188 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7179 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7158 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7158 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7157 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7125 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7112 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7107 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7077 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7066 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7049 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7018 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7005 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD411 |
Approved |
0.6977 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.697 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6949 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6935 |
Remote Similarity |
NPD7584 |
Approved |
0.6931 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6927 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6927 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD9545 |
Approved |
0.6923 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6919 |
Remote Similarity |
NPD8319 |
Approved |
0.6918 |
Remote Similarity |
NPD1608 |
Approved |
0.6914 |
Remote Similarity |
NPD7458 |
Discontinued |
0.691 |
Remote Similarity |
NPD4288 |
Approved |
0.691 |
Remote Similarity |
NPD5353 |
Approved |
0.6908 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD2309 |
Approved |
0.6898 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD3268 |
Approved |
0.689 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6852 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6852 |
Remote Similarity |
NPD2798 |
Approved |
0.6845 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6832 |
Remote Similarity |
NPD3225 |
Approved |
0.6831 |
Remote Similarity |
NPD5242 |
Approved |
0.6829 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6821 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD5006 |
Approved |
0.6818 |
Remote Similarity |
NPD5005 |
Approved |
0.6815 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6795 |
Remote Similarity |
NPD9493 |
Approved |
0.679 |
Remote Similarity |
NPD2797 |
Approved |
0.679 |
Remote Similarity |
NPD1470 |
Approved |
0.6788 |
Remote Similarity |
NPD3764 |
Approved |
0.6788 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6784 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6784 |
Remote Similarity |
NPD7680 |
Approved |
0.6782 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6771 |
Remote Similarity |
NPD4287 |
Approved |
0.6766 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6762
|
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |